Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Eli Lilly & Company
EIR
•Eli Lilly & Company•January 17, 2020

FDA EIR - Eli Lilly & Company - January 17, 2020

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Eli Lilly & Company
Record Details

This EIR record concerns Eli Lilly & Company, with an inspection on January 17, 2020.

Company
Eli Lilly & Company
Inspection Date
January 17, 2020
People
  • Myra K. Casey (U.S. Food and Drug Administration)
  • Charles J. Chacko
  • Jolanna A. Norton (Investigator)
  • LaTonya Mitchell-Holmes (Program Division Director)
  • David G (Acting Chief Scientist)
Open in Dashboard

ID · 00535940-b628-4bcd-aa01-17eb95be770e

KeyPedia
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@globalkeysolutions.net
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.